2019 n-CoV
News
2020.07.22
Aptamers can be thought of as analogs of antibodies entirely composed of nucleic acids (DNA or RNA). They can be used in a wide range of applications but they...
News
2020.07.03
The ARIA software suite developed at Institut Pasteur automates the analysis of NMR data to calculate three-dimensional structures of macromolecules. To...
News
2021.05.05
Malaria remains a major public health burden in some world regions. In 2018, 237,000 cases were reported in Brazil, 91.5% of them caused by the parasite...
News
2021.04.26
Preventive vaccination is a powerful tool in controlling viral outbreaks. It is important that any side effects associated with the use of vaccines are as mild...
Document de presse
2020.07.01
The gut microbiota houses a complex and varied microbial community that coexists in a balance which is crucial for human health but poorly understood. In this...
News
2021.03.30
Since the beginning of the COVID-19 pandemic, and increasingly rapidly thereafter, the Institut Pasteur International Network has drawn heavily on all its...
News
2021.03.30
Immunotherapy, or the notion of "retraining" patients' immune systems, constitutes a major step forward in the fight against cancer. Although the results of...
Document de presse
2021.03.23
SARS-CoV-2, the virus responsible for COVID-19, is capable of infecting some species, while others are naturally resistant to it. This determines the "host...
Document de presse
2021.03.26
The B.1.1.7 and B.1.351 variants of SARS-CoV-2 were first detected in the UK and South Africa respectively, and have since spread to many other countries....
News
2021.03.24
ERA4TB (the European Regimen Accelerator for Tuberculosis) is a 6-year public-private partnership with a total budget of over €200M that began in 2020 with the...